Malvern, PA, September 16, 2015 – SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain, today announced that the FDA has accepted for filing...

Read more

Dr. Sanjay Gupta, President of the American Pain Association and a renowned physician with pain management expertise Dr. Philip Gerbino, an award-winning global pharmaceutical consultant and industry expert on market access MALVERN, Pa., June...

Read more

SCILEX PHARMACEUTICALS ANNOUNCES STRATEGIC INVESMENT BY ITOCHU CHEMICAL FRONTIER CORPORATION Malvern, PA – March 19, 2015 – SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain, today...

Read more

SCILEX TO PRESENT AT AEGIS CAPITAL HEALTHCARE & TECHNOLOGY CONFERENCE   MALVERN, PA. September 10, 2014 /PRNewswire/ — SCILEX Pharmaceuticals Inc., a company engaged in the development and commercialization of products focused on the treatment of...

Read more

Please click the link below to read the complete article. http://www.bizjournals.com/philadelphia/blog/health-care/2014/08/pain-drug-developer-reels-in-5.html

Read more

Mr. Sendrow Joins Pharmaceuticals Product Development and Regulatory Expert Eric Floyd, Ph.D. on the Board Malvern, PA – SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain,...

Read more

Pivotal pharmacokinetic bridging clinical study anticipated to begin in May. Malvern, PA – SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products for the treatment of pain, today announced that it...

Read more

Funds to be used for the clinical development of the Company’s first product Ztlido™ (lidocaine patch 1.8%) Malvern, PA – SCILEX Pharmaceuticals, Inc., today announced that the company has entered into definitive agreements for a...

Read more